Punarjani Institute Of Medical Science And Research Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 17-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 17-12-2024
- Company Age 18 Year, 1 Month
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 5.23 Cr
as on 17-12-2024
- Satisfied Charges ₹ 6.25 Cr
as on 17-12-2024
- Revenue 0.11%
(FY 2017)
- Profit 166.90%
(FY 2017)
- Ebitda 41.20%
(FY 2017)
- Net Worth 56.16%
(FY 2017)
- Total Assets 4.89%
(FY 2017)
About Punarjani Institute Of Medical Science And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹5.23 Cr. The company has closed loans amounting to ₹6.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Satheeshkumar Velayodhannair, Hrishikesh Elenjickal, and Sudhi Rajan serve as directors at the Company.
- CIN/LLPIN
U85110KL2006PTC020007
- Company No.
020007
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2006
- Date of AGM
28 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Punarjani Institute Of Medical Science And Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satheeshkumar Velayodhannair  | Director | 20-Nov-2006 | Current |
| Hrishikesh Elenjickal | Additional Director | 23-Feb-2015 | Current |
| Sudhi Rajan | Additional Director | 19-Feb-2015 | Current |
Financial Performance of Punarjani Institute Of Medical Science And Research.
Punarjani Institute Of Medical Science And Research Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 0.11% increase. The company also saw a substantial improvement in profitability, with a 166.9% increase in profit. The company's net worth Soared by an impressive increase of 56.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Punarjani Institute Of Medical Science And Research?
In 2017, Punarjani Institute Of Medical Science And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Catholic Syrian Bank Ltd Creation Date: 26 Jun 2014 | ₹3.00 M | Open |
The Catholic Syrian Bank Ltd Creation Date: 04 Mar 2013 | ₹4.93 Cr | Open |
Bank Of Baroda Creation Date: 28 Mar 2007 | ₹6.25 Cr | Satisfied |
How Many Employees Work at Punarjani Institute Of Medical Science And Research?
Unlock and access historical data on people associated with Punarjani Institute Of Medical Science And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Punarjani Institute Of Medical Science And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Punarjani Institute Of Medical Science And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
